Andreas Schönau

648 total citations
21 papers, 451 citations indexed

About

Andreas Schönau is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Andreas Schönau has authored 21 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Andreas Schönau's work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Advanced Biosensing Techniques and Applications (4 papers). Andreas Schönau is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Advanced Biosensing Techniques and Applications (4 papers). Andreas Schönau collaborates with scholars based in Denmark, United States and Italy. Andreas Schönau's co-authors include Ann Knoop, Bent Ejlertsen, Kirsten Vang Nielsen, Eva Balslev, Birgitte Rasmussen, Helle Knudsen, Jens Overgaard, Karen Ege Olsen, K. Gunnarsdóttir and Henning T. Mouridsen and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Immunological Methods and American Journal of Clinical Pathology.

In The Last Decade

Andreas Schönau

18 papers receiving 438 citations

Peers

Countries citing papers authored by Andreas Schönau

Since Specialization

Citations

This map shows the geographic impact of Andreas Schönau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Schönau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Schönau more than expected).

Fields of papers citing papers by Andreas Schönau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Schönau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Schönau. The network helps show where Andreas Schönau may publish in the future.

Co-authorship network of co-authors of Andreas Schönau

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Schönau. A scholar is included among the top collaborators of Andreas Schönau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Schönau. Andreas Schönau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Stereologic consequences of iatrogenic collapse: The morphology of adenocarcinoma in situ overlaps with invasive patterns. Proposal for a necessary modified classification of pulmonary adenocarcinomas 2024 ·Lung Cancer ·(unknown), Hans Blaauwgeers, Birgit I. Lissenberg‐Witte, Andreas Schönau, Claudio Doglioni, Gianluigi Arrigoni, Teodora Radonic, Idris Bahce, (unknown), Chris Dickhoff, (unknown), Alessandra Bulotta, Yuko Minami, Masayuki Noguchi, Francesca Ambrosi, Erik Thunnissen	0
2	"In the spectrum of people who are healthy": Views of individuals at risk of dementia on using neurotechnology for cognitive enhancement 2024 ·Neuroethics ·Asad Beck, Andreas Schönau, (unknown), (unknown), (unknown), Dong Song, Sara Goering, Eran Klein	1
3	Loose Tumor Cells in Pulmonary Arteries of Lung Adenocarcinoma Resection Specimens: No Correlation With Survival, Despite High Prevalence 2023 ·Archives of Pathology & Laboratory Medicine ·Hans Blaauwgeers, (unknown), Birgit I. Lissenberg‐Witte, Claudio Doglioni, Teodora Radonic, Idris Bahce, Yuko Minami, Andreas Schönau, (unknown), Adrianus A. J. Smit, Chris Dickhoff, Erik Thunnissen	0
4	Views of stakeholders at risk for dementia about deep brain stimulation for cognition 2023 ·Brain stimulation ·Eran Klein, (unknown), (unknown), (unknown), Andreas Schönau, (unknown), Dong Song, Sara Goering	3
5	Agency in augmented reality: exploring the ethics of Facebook’s AI-powered predictive recommendation system 2022 ·AI and Ethics ·Andreas Schönau	3
6	Asking questions that matter – Question prompt lists as tools for improving the consent process for neurotechnology clinical trials 2022 ·Frontiers in Human Neuroscience ·Andreas Schönau, Sara Goering, (unknown), (unknown), Timothy Brown, (unknown), Eran Klein	3
7	The Spectrum of Responsibility Ascription for End Users of Neurotechnologies 2021 ·Neuroethics ·Andreas Schönau	7
8	Mapping the Dimensions of Agency 2021 ·AJOB Neuroscience ·Andreas Schönau, (unknown), Timothy Brown, (unknown), Eran Klein, Sara Goering	15
9	P2.09-16 Assessment of PD-L1 and CD8 Expression in Lung Cancer Using RNA in Situ Hybridisation 2019 ·Journal of Thoracic Oncology ·Anne‐Marie Baird, (unknown), (unknown), (unknown), Andreas Schönau, Sinéad Cuffe, Stephen P. Finn, Steven G. Gray	0
10	Schnittstellenprobleme in Neurowissenschaften und Philosophie 2019 ·J.B. Metzler eBooks ·Andreas Schönau	3
11	Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization 2012 ·BMC Clinical Pathology ·Jens Mollerup, Ulla Henriksen, Sven Müller, Andreas Schönau	18
12	High Concordance Between Two Companion Diagnostics Tests 2011 ·American Journal of Clinical Pathology ·Jan Trøst Jørgensen, Susanne Möller, Birgitte Rasmussen, Henrik Winther, Andreas Schönau, Ann Knoop	17
13	Visualization of FISH Probes by Dual-Color Chromogenic In Situ Hybridization 2010 ·American Journal of Clinical Pathology ·(unknown), Jan Trøst Jørgensen, Sven Müller, (unknown), Ole Ø. Rasmussen, Andreas Schönau	17
14	Aberrations of ERBB2 and TOP2A genes in breast cancer 2009 ·Molecular Oncology ·Kirsten Vang Nielsen, Sven Müller, Susanne Möller, Andreas Schönau, Eva Balslev, Ann Knoop, Bent Ejlertsen	27
15	Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group 2005 ·Journal of Clinical Oncology ·Ann Knoop, Helle Knudsen, Eva Balslev, Birgitte Rasmussen, Jens Overgaard, Kirsten Vang Nielsen, Andreas Schönau, K. Gunnarsdóttir, Karen Ege Olsen, Henning T. Mouridsen, Bent Ejlertsen	244
16	Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes 2004 ·Acta Oncologica ·Karen Ege Olsen, Helle Knudsen, Birgitte Rasmussen, Eva Balslev, Ann Knoop, Bent Ejlertsen, Kirsten Vang Nielsen, Andreas Schönau, Jens Overgaard, (unknown)	61
17	Detection of gamma‐globin mRNA in fetal nucleated red blood cells by PNA fluorescence in situ hybridization 2003 ·Prenatal Diagnosis ·(unknown), Andreas Schönau, (unknown), Kenneth H. Petersen, Jesper Lohse, Britta Christensen, John Philip, (unknown)	8
18	674 Topoisomerase II alpha (TOP2A) alterations as a predictive marker for epirubicin sensitivity in 805 high-risk breast cancer patients. A randomised DBCG trial (DBCG89D) 2003 ·European Journal of Cancer Supplements ·Ann Knoop, Helle Knudsen, Eva Balslev, Blake B. Rasmussen, Jens Overgaard, Kirsten Vang Nielsen, Andreas Schönau, K. Gunnarsdóttir, H.T. Mouridsen, Bent Ejlertsen	6
19	Amplified In Situ Hybridization With Peptide Nucleic Acid Probes for Differentiation ofMycobacterium tuberculosisComplex and NontuberculousMycobacteriumSpecies on Formalin-Fixed, Paraffin-Embedded Archival Biopsy and Autopsy Samples 2001 ·American Journal of Clinical Pathology ·Pietro Zerbi, Andreas Schönau, Sara Bonetto, Andrea Gori, Giulio Costanzi, Piergiorgio Duca, Luca Vago	14
20	A one-step solid phase immunoassay for simultaneous detection of serum IgG and IgM antibodies to Borrelia burgdorferi 1998 ·Journal of Immunological Methods ·Andreas Schönau, Henrik Stender, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact